Pain. Acute Pain
Conditions
Interventions
Intervention 1: Drugs:
1-Ketamine:
Dose: 0.5mg/kg
Number of using: Once
Factory name: Rotex medica
Manufacturing Country's Name: Germany
Location prescribed: In place of incision Subcutaneously
Treatment - Drugs
Placebo
Drugs:
1-Ketamine:
Dose: 0.5mg/kg
Number of using: Once
Factory name: Rotex medica
Manufacturing Country's Name: Germany
Location prescribed: In place of incision Subcutaneously
Administr
Drug:
Normal Saline
Dose: 10 ml
Number of using: Once
Factory name: Daroupakhsh
Manufacturing Country's Name: Iran
Location prescribed: In place of incision Subcutaneously
Administration t
Drugs:
1-Ketamine:
Dose: 0.5mg/kg
Number of using: Once
Factory name: Rotex medica
Manufacturing Country's Name: Germany
Location prescribed: In place of incision Subcutaneously
Administrat
Sponsors
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: - The patient's satisfaction – Age between 20 and 40 years old - ASA class I & II Exclusion criteria: - The lack of patient's satisfaction to spinal anesthesia - History of hypnotics or narcotics throughout 24 hours before the surgery - History of drug abuse, or alcohol- dependency - Contraindication of Ketamine - Contraindications of Spinal Anesthesia( Patient refusal ; Infection at the site of planned needle puncture ; Elevated intracranial pressure and Bleeding diathesis)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 1,2,4,6,12,18 and 24 hours after surgery. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Opioid Consumption. Timepoint: 24 hours after surgery. Method of measurement: Milligram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Aslani
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed